{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:14:15Z","timestamp":1790709255125,"version":"4.1.0"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103294","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T22:44:49Z","timestamp":1406933089000},"page":"e103294","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency"],"prefix":"10.1371","volume":"9","author":[{"given":"Simon E.","family":"Hufton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Risley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmar G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/296115a0","article-title":"Molecular mechanisms of variation in influenza viruses","volume":"296","author":"RG Webster","year":"1982","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","article-title":"The 2009 A (H1N1) influenza virus pandemic: A review","volume":"28","author":"MP Girard","year":"2010","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918-1920 \u201cSpanish\u201d influenza pandemic","volume":"76","author":"NP Johnson","year":"2002","journal-title":"Bull Hist Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/INF.0b013e3181684d2d","article-title":"H5N1 transmission and disease: observations from the frontlines","volume":"27","author":"J de","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"S Herfst","year":"2012","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"M Imai","year":"2012","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp068030","article-title":"Antiviral resistance in influenza viruses\u2014implications for management and pandemic response","volume":"354","author":"FG Hayden","year":"2006","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/187152607783018736","article-title":"Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic","volume":"7","author":"AC Lowen","year":"2007","journal-title":"Infect Disord Drug Targets"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1210-1389","article-title":"Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine","volume":"16","author":"GJ Nabel","year":"2010","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"WA Marasco","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08830180802593540","article-title":"Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery","volume":"28","author":"O Martinez","year":"2009","journal-title":"Int Rev Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"TC Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"B Zhou","year":"2007","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"G33","DOI":"10.1016\/j.vaccine.2009.09.137","article-title":"Anti-infective antibodies\u2014reviving an old paradigm","volume":"27","author":"P Lachmann","year":"2009","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.158.3.1222","article-title":"Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice","volume":"158","author":"SL Epstein","year":"1997","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"J Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"DC Ekiert","year":"2009","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"M Throsby","year":"2008","journal-title":"PLoS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies","volume":"105","author":"AK Kashyap","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"DC Ekiert","year":"2011","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"D Corti","year":"2011","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"C Dreyfus","year":"2012","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"G Nakamura","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"R Wang","year":"2008","journal-title":"Antiviral Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1743-422X-6-224","article-title":"Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein","volume":"6","author":"RR Beerli","year":"2009","journal-title":"Virol J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"RJ Russell","year":"2006","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"MW Lamere","year":"2011","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"JJ Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"RJ Russell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.virol.2004.04.040","article-title":"H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes","volume":"325","author":"RJ Russell","year":"2004","journal-title":"Virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JVI.79.5.2814-2822.2005","article-title":"Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls","volume":"79","author":"RA Fouchier","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"D Corti","year":"2010","journal-title":"J Clin Invest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ni.1746","article-title":"HIV-1 and influenza antibodies: seeing antigens in new ways","volume":"10","author":"PD Kwong","year":"2009","journal-title":"Nat Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120","volume":"445","author":"T Zhou","year":"2007","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir121","article-title":"Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies","volume":"52","author":"J Sui","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"J Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-5793(97)01062-4","article-title":"Selection and identification of single domain antibody fragments from camel heavy-chain antibodies","volume":"414","author":"GM Arbabi","year":"1997","journal-title":"FEBS Lett"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"C Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis","volume":"54","author":"K Coppieters","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"S Muyldermans","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/v2020532","article-title":"Developing vaccines to combat pandemic influenza","volume":"2","author":"JS Robertson","year":"2010","journal-title":"Viruses"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jim.2007.04.008","article-title":"Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)","volume":"324","author":"DR Maass","year":"2007","journal-title":"J Immunol Methods"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"MM Harmsen","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1074\/jbc.274.26.18218","article-title":"A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies","volume":"274","author":"HJ de Haard","year":"1999","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nbt1067","article-title":"Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity","volume":"23","author":"RM Hoet","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jmb.2009.03.019","article-title":"Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions","volume":"388","author":"WJ Finlay","year":"2009","journal-title":"J Mol Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/JCM.26.2.333-337.1988","article-title":"Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection","volume":"26","author":"MW Harmon","year":"1988","journal-title":"J Clin Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e36438","DOI":"10.1371\/journal.pone.0036438","article-title":"International network for comparison of HIV neutralization assays: the NeutNet report II","volume":"7","author":"L Heyndrickx","year":"2012","journal-title":"PLoS ONE"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2005.09.034","article-title":"Analyzing a kinetic titration series using affinity biosensors","volume":"349","author":"R Karlsson","year":"2006","journal-title":"Anal Biochem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.antiviral.2010.09.007","article-title":"A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection","volume":"88","author":"S Sakabe","year":"2010","journal-title":"Antiviral Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Y Okuno","year":"1993","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6750-12-77","article-title":"Pandemic influenza vaccine: characterization of A\/California\/07\/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability","volume":"12","author":"E Feshchenko","year":"2012","journal-title":"BMC Biotechnol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0161-5890(00)00081-X","article-title":"Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features","volume":"37","author":"MM Harmsen","year":"2000","journal-title":"Mol Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/emboj\/19.5.921","article-title":"Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire","volume":"19","author":"VK Nguyen","year":"2000","journal-title":"EMBO J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/333426a0","article-title":"Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid","volume":"333","author":"W Weis","year":"1988","journal-title":"Nature"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/bst0110145","article-title":"The structure and role of the carbohydrate moieties of influenza virus haemagglutinin","volume":"2","author":"IA Wilson","year":"1983","journal-title":"Biochem Soc Trans 11 Pt"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nm0113-12","article-title":"A universal problem","volume":"19","author":"H Hoag","year":"2013","journal-title":"Nat Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"PS Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1099\/0022-1317-78-10-2431","article-title":"Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments","volume":"10)","author":"DJ Schofield","year":"1997","journal-title":"J Gen Virol 78 (Pt"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/prot.340230113","article-title":"Crystallization and preliminary X-ray diffraction studies of complexes between an influenza hemagglutinin and Fab fragments of two different monoclonal antibodies","volume":"23","author":"B Gigant","year":"1995","journal-title":"Proteins"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"A Hultberg","year":"2011","journal-title":"PLoS ONE"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1074\/jbc.M307341200","article-title":"Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm","volume":"279","author":"B Stijlemans","year":"2004","journal-title":"J Biol Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-2836(02)01222-6","article-title":"Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen","volume":"325","author":"AV Collis","year":"2003","journal-title":"J Mol Biol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"DC Ekiert","year":"2012","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2183\/pjab.88.226","article-title":"Molecular basis of the structure and function of H1 hemagglutinin of influenza virus","volume":"88","author":"N Sriwilaijaroen","year":"2012","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"12205","DOI":"10.1073\/pnas.92.26.12205","article-title":"A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation","volume":"92","author":"J Chen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1128\/JVI.01379-08","article-title":"Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120","volume":"82","author":"A Forsman","year":"2008","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1128\/JVI.00436-08","article-title":"Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice","volume":"82","author":"L Garaicoechea","year":"2008","journal-title":"J Virol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2006.02.045","article-title":"Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments","volume":"24","author":"d van","year":"2006","journal-title":"Vaccine"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.22609","article-title":"Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice","volume":"49","author":"B Serruys","year":"2009","journal-title":"Hepatology"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","article-title":"Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection","volume":"203","author":"LI Ibanez","year":"2011","journal-title":"J Infect Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1110\/ps.34602","article-title":"Single-domain antibody fragments with high conformational stability","volume":"11","author":"M Dumoulin","year":"2002","journal-title":"Protein Sci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1128\/AEM.71.1.442-450.2005","article-title":"Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo","volume":"71","author":"E Dolk","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"C Vincke","year":"2009","journal-title":"J Biol Chem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1074\/jbc.M513415200","article-title":"Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies","volume":"281","author":"J Shen","year":"2006","journal-title":"J Biol Chem"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","article-title":"Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins","volume":"26","author":"S Chun","year":"2008","journal-title":"Vaccine"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e1000049","DOI":"10.1371\/journal.pmed.1000049","article-title":"Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets","volume":"6","author":"S Khurana","year":"2009","journal-title":"PLoS Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T17:59:12Z","timestamp":1689443952000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103294"}},"subtitle":[],"editor":[{"given":"Stefan","family":"P\u00f6hlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":77,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103294","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}